Related Experiment Video
Updated: Aug 14, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Factors affecting diurnal variability of ventricular tachyarrhythmias detected by multiprogrammable implantable
Astin K Y Lee1, Mahidi Mardini, David L Ross
1Department of Cardiology, Westmead Hospital, Westmead, New South Wales 2145, Australia.
Insights
Cardiovascular events like ventricular arrhythmias show a distinct morning peak. Antiarrhythmic drugs like amiodarone may alter this circadian pattern in patients with implantable cardioverter-defibrillators (ICDs).
Area of Science:
- Cardiology
- Chronobiology
- Medical Devices
Background:
- Many cardiovascular events exhibit diurnal variability, often with a morning peak.
- Implantable cardioverter-defibrillators (ICDs) allow for detailed analysis of ventricular tachyarrhythmic events.
Purpose of the Study:
- To evaluate the circadian pattern of ventricular tachycardias in patients with ICDs.
- To examine the influence of antiarrhythmic medications on this circadian pattern.
Main Methods:
- Manual analysis of data from 83 patients' ICDs.
- Exclusion of non-ventricular arrhythmia events.
- Assessment of event timing and correlation with patient characteristics and medications.
Main Results:
- A significant morning peak for ventricular arrhythmias was observed around 9:00 a.m.
- This morning peak persisted in patients with reduced ejection fractions (<40%) and short arrhythmia cycle lengths (<230ms).
- Beta-blockers did not affect the morning peak, whereas amiodarone appeared to delay its occurrence.
Conclusions:
- Ventricular arrhythmias demonstrate a clear circadian rhythm with a morning predominance.
- Specific patient subgroups (low ejection fraction, short cycle length) maintain this pattern.
- Amiodarone may modify the timing of ventricular tachyarrhythmias, suggesting a potential interaction with circadian mechanisms.
Abstract:
Many cardiovascular events, including ventricular arrhythmias, display diurnal variability with a morning peak, and a less pronounced afternoon peak. Since the advent of multiprogrammable implantable cardioverter-defibrillators (ICDs), it has been possible to analyse ventricular tachyarrhythmic events. This study aims to evaluate the circadian pattern of ventricular tachycardias in patients treated with ICDs and examines whether antiarrhythmic medications affect this pattern. Data recorded from 83 patients' ICDs were manually analysed and events other than ventricular arrhythmias were excluded. There was a morning peak of ventricular arrhythmias at around 9.00 a.m. This peak was maintained in patients with ejection fractions of less than 40% and those whose arrhythmias had cycle lengths of less than 230ms. Beta blockers appeared to have no effect on this morning peak but the peak appeared later with amiodarone.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Dysrhythmias V: Evaluating Dysrhythmias
